open access to scientific and medical research

Back to Journals » Research Reports in Clinical Cardiology » Volume 4

Review

Noteworthy Comment: The biology and current status of CETP inhibition as a therapeutic target are authoritatively presented in this re-evaluation. Anacetrapib, a potent CETP inhibitor, may prove to be a valuable addition to the clinician's armamentarium.

Highly-accessed

Anacetrapib: potential for the prevention and treatment of coronary heart disease

Total article views		HTML views	PDF downloads	Totals
10,722	Dovepress*	10,722+	3,379	14,101
10,722	Totals	10,722	3,379	14,101
*Since 4 April 2013 +Since July 2016

View citations on Google Scholar